Proving that awareness for triple negative breast cancer forges on right through March and beyond, members from the Triple Negative Breast Cancer Foundation rang the opening bell of the New York Stock Exchange this morning.
Triple Negative Breast Cancer Foundation® was founded in 2006 in honor of Nancy Block-Zenna, a young woman who was diagnosed at age 35 with triple negative breast cancer and died 2 1/2 years later in 2007. In response to Nancy's diagnosis, her close friends launched the TNBC Foundation® to raise awareness and support research in the area of triple negative breast cancer.
Triple Negative Breast Cancer Day, officially marked on March 3, 2014 was a day initiated by the Triple Negative Breast Cancer Foundation ® in order to bring education, awareness, and funding for this little known subtype of breast cancer.
Triple negative is a subtype of breast cancer that lacks three important receptors-known as estrogen receptor (ER), progesterone receptor (PR) or Human Epidermal growth factor Receptor 2 (HER-2/neu)-shown to fuel most breast cancers and are used for treatment.
Testing negative for all three of these hormone receptors means the cancer is triple negative. Triple negative breast cancer does not respond to hormone treatments, making chemotherapy, radiation, and surgery the current main options for survival.
By ringing the bell of the NYSE, Executive Director of the Triple Negative Breast Cancer Foundation, Hayley Dinerman brings the light of a national stage to this little known disease.
Caregivers, survivors, and supporters throughout the country continue hosting their own events to bring awareness and much needed funding to bring an end to this disease.
For more information on the Triple Negative Breast Cancer Foundation or to learn how to start your own event please visit their website.